Venturis Therapeutics, Inc.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease	Arterial Occlusive Diseases, Constriction, Pathologic, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder	Not yet recruiting	Phase 1 / Phase 2	2026-08-19		NCT00424866
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease	Arterial Occlusive Diseases, Coronary Arteriosclerosis, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder	Not yet recruiting	Phase 2	2026-08-19		NCT00117936

Clinical trials